Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2016-03-01 Declaration of Voting R…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and contains detailed tables reporting changes in voting rights attached to shares and instruments (options) held by BNY Mellon Service Kapitalanlage-Gesellschaft mbH in STADA Arzneimittel AG, referencing specific sections of the German Securities Trading Act (WpHG). This content directly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the specific content structure (reporting thresholds crossed, detailed breakdown of holdings) aligns best with MRQ, which covers changes in significant share ownership.
2016-03-01 English
STADA Arzneimittel AG: Development as expected in 2015 under difficult framework conditions - dividend to increase - preliminary outlook for 2016 published
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement published on February 29, 2016, detailing the 'preliminary figures for financial year 2015'. It explicitly states that the figures are 'not yet been audited' and provides key financial metrics (sales, EBITDA, net income) and an outlook for 2016. This content—the initial release of key financial results for a period (the full year 2015) before the final audited report—fits the definition of an Earnings Release (ER). Although it covers the full year, it is a preliminary announcement, not the comprehensive 10-K. It is not a transcript (CT), a presentation (IP), or a notice of a future report publication (RPA). FY 2015
2016-02-29 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and contains sections detailing the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in voting rights percentages (3.05% direct, 0.99% via instruments) held by BNY Mellon Service Kapitalanlage-Gesellschaft mbH in STADA Arzneimittel AG. This directly corresponds to the definition of reporting changes in significant share ownership thresholds, which aligns best with the Major Shareholding Notification (MRQ) category. Although the header mentions 'Voting Rights Announcements', the content is a specific notification of a major holding crossing a threshold, which is the core function of an MRQ filing.
2016-02-29 English
STADA Arzneimittel AG: Appointment of Dr. Matthias Wiedenfels extended
Board/Management Information Classification · 98% confidence The document is a press release announcing the extension of the appointment for Dr. Matthias Wiedenfels, a member of the Executive Board of STADA Arzneimittel AG. This type of announcement concerns changes in senior management personnel. Based on the provided definitions, the category 'Board/Management Information' (Code: MANG) is the most appropriate classification for news regarding the appointment or contract extension of executive officers.
2016-01-11 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages and the instruments causing those changes (warrants, options) for a specific shareholder (Societe Generale S.A.). This directly corresponds to the definition of a filing related to changes in significant share ownership thresholds. The category 'Major Shareholding Notification' (MRQ) is the most appropriate fit, as it covers notifications of changes in significant share ownership levels crossing thresholds, which is the core content here, even though the header mentions 'Voting Rights Announcements'.
2015-12-23 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages (both attached to shares and through instruments) for a specific entity (Societe Generale S.A.) in STADA Arzneimittel AG, referencing German securities law (WpHG). This content directly aligns with the definition of reporting changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the disclosure of major holdings/voting rights changes, making MRQ the most precise fit over DVA (which is for voting results) or RNS (the general fallback).
2015-12-22 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.